XML 65 R58.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Technology License Agreement - Additional Information (Details) - BWH License - USD ($) |  |  | 3 Months Ended
--- | --- | --- | ---
Sep. 15, 2020 | Jan. 20, 2018 | Mar. 31, 2024 | Mar. 31, 2023
Technology License Agreement [Line Items] |  |  |  |
Committed amount to remitting in support of clinical trial |  | $ 800,000 |  |
Committed period to remitting in support of clinical trial |  | 3 years |  |
Non-refundable fee |  | $ 40,000 |  |
Expense for startup and patient fees for clinical trials |  |  | $ 0 | $ 0
Payment for license fee | $ 100,000 |  |  |
Payment at the time of entering into license | 100,000 |  |  |
Payment for annual license fee | 50,000 |  |  |
Maximum amount upon achievement of various clinical, commercial and sales milestones | $ 39,000,000 |  |  |

X
- Definition Committed amount to remitting in support of clinical trial. + References No definition available. + Details
Name: | cadl_CommittedAmountToRemittingInSupportOfClinicalTrial
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Committed period to remitting in support of clinical trial. + References No definition available. + Details
Name: | cadl_CommittedPeriodToRemittingInSupportOfClinicalTrial
Namespace Prefix: | cadl_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expense for startup and patient fees for clinical trials. + References No definition available. + Details
Name: | cadl_ExpenseForStartupAndPatientFeesForClinicalTrials
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum amount upon achievement of various clinical, commercial and sales milestones. + References No definition available. + Details
Name: | cadl_MaximumAmountUponAchievementOfVariousClinicalCommercialAndSalesMilestones
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Non-refundable fee. + References No definition available. + Details
Name: | cadl_NonRefundableFee
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payment at the time of entering into license. + References No definition available. + Details
Name: | cadl_PaymentAtTimeOfEnteringIntoLicense
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payment for annual license fee. + References No definition available. + Details
Name: | cadl_PaymentForAnnualLicenseFee
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payment for license fee. + References No definition available. + Details
Name: | cadl_PaymentForLicenseFee
Namespace Prefix: | cadl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Technology license agreement. + References No definition available. + Details
Name: | cadl_TechnologyLicenseAgreementLineItems
Namespace Prefix: | cadl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cadl_BrighamAndWomensHospitalIncLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |